Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Higher testosterone and DHT levels are not linked to urinary symptoms in men.

Male accessory sex glands in rats rarely develop tumors and respond to hormones.

Androgens may influence bladder cancer progression by affecting cellular behavior.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

The plant extracts may help treat hair loss by promoting hair growth and reducing DHT levels.

High testosterone to epitestosterone ratio in hair could predict male-pattern baldness.

Sansevieria trifasciata P. extracts, especially the ethyl acetate fraction, effectively promote hair growth in male rabbits with hair loss.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

A topical treatment safely and effectively reduced acne by causing targeted cell death in sebaceous glands without side effects.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Moringa seed oil helped hair growth in rabbits, with the highest dose being most effective.

Artemis dysfunction might cause hair loss through telomere shortening.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

The research gives new understanding on how human steroid 5α-reductases work and how drugs like finasteride inhibit them, which could help in creating new drugs.

Androgen levels can increase at any age, affecting symptoms like acne, hair loss, and prostate size.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Antiandrogen therapy may help treat hidradenitis suppurativa.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

Topical finasteride doesn't reduce DHT levels, hinting at an endocrine role in hair loss.

Finasteride reduces testosterone conversion, progesterone lessens this, and levamisole enhances finasteride's effect.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

Male pattern baldness is often genetic and linked to a hormone, with treatments like finasteride and minoxidil being effective for some men.

Electro-acupuncture may help treat PCOS in rats by changing brain DNA methylation.

Human keratinocytes do not naturally respond to androgens.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

Minocycline may cause hair loss by increasing DHT levels, but finasteride can help counteract this effect.